Insider · CIK 0001780235

O'Donnell Niall

Reports to the SEC for 3 companies · ST. LOUIS, MO

sec.gov

Transactions

Companies

Filings

CIK

0001780235

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-06	OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2023-05-25	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-05-08	OKUROnKure Therapeutics, Inc.P Purchase	Director	PPurchase	+125K sh	$8.00	+$1M	2,188,713
2023-02-16	SPRBSPRUCE BIOSCIENCES, INC.P Purchase	Director	PPurchase	+630K sh	$3.17	+$2M	1,326,305
2023-02-16	SPRBSPRUCE BIOSCIENCES, INC. · Common Stock Warrant (Right to Buy)P Purchase	Director	PPurchase	+473K sh	—	—	472,800
2022-11-15	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−93.8K sh	$19.69	−$1.85M	1,621,118
2022-11-14	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−32.1K sh	$19.60	−$629K	1,714,888
2022-11-11	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−174K sh	$19.99	−$3.48M	1,746,997
2022-06-02	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17K sh	—	—	17,000
2022-06-01	OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2022-05-25	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2021-06-04	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17K sh	—	—	17,000
2021-05-20	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-04-13	OKUROnKure Therapeutics, Inc.C Conversion	Director	CConversion	+1.03M sh	—	—	1,034,600
2021-04-13	OKUROnKure Therapeutics, Inc.C Conversion	Director	CConversion	+829K sh	—	—	1,863,713
2021-04-13	OKUROnKure Therapeutics, Inc.P Purchase	Director	PPurchase	+200K sh	$15.00	+$3M	2,063,713
2021-04-13	OKUROnKure Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−4.63M sh	—	—	0
2021-04-13	OKUROnKure Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−3.71M sh	—	—	0
2021-04-08	OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2020-10-14	SPRBSPRUCE BIOSCIENCES, INC.C Conversion	Director	CConversion	+446K sh	—	—	445,905
2020-10-14	SPRBSPRUCE BIOSCIENCES, INC.P Purchase	Director	PPurchase	+250K sh	$15.00	+$3.75M	695,905
2020-10-14	SPRBSPRUCE BIOSCIENCES, INC. · Series B Preferred StockC Conversion	Director	CConversion	−2.92M sh	—	—	0
2020-06-11	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17K sh	—	—	17,000
2019-07-22	MIRMMirum Pharmaceuticals, Inc.C Conversion	Director	CConversion	+1.5M sh	—	—	1,621,118
2019-07-22	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+300K sh	$15.00	+$4.5M	1,921,118
2019-07-22	MIRMMirum Pharmaceuticals, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−12M sh	—	—	0

Recent filings

Accepted (ET)
Jun 84
O'Donnell Niall0001209191-23-035562
SEC(opens sec.gov)
May 264
O'Donnell Niall0001209191-23-032659
SEC(opens sec.gov)
May 164
O'Donnell Niall0001209191-23-029764
SEC(opens sec.gov)
May 104
O'Donnell Niall0001209191-23-028533
SEC(opens sec.gov)
Nov 154
O'Donnell Niall0000899243-22-035944
SEC(opens sec.gov)
Jun 64
O'Donnell Niall0001209191-22-034628
SEC(opens sec.gov)
Jun 34
O'Donnell Niall0001209191-22-034175
SEC(opens sec.gov)
May 274
O'Donnell Niall0001209191-22-032519
SEC(opens sec.gov)
Jun 84
O'Donnell Niall0001209191-21-038932
SEC(opens sec.gov)
May 214
O'Donnell Niall0001209191-21-035150
SEC(opens sec.gov)
Apr 154
O'Donnell Niall0001209191-21-026826
SEC(opens sec.gov)
Apr 124
O'Donnell Niall0001209191-21-026340
SEC(opens sec.gov)
Oct 164
O'Donnell Niall0001209191-20-055015
SEC(opens sec.gov)

Companies

Address

C/O RIVERVEST VENTURE PARTNERS 101 SOUTH HANLEY ROAD, STE. 1850

ST. LOUIS, MO, 63105